# Utilization of AMSC to Enhance Rotator Cuff Repair - Safety and Efficacy

> **NCT03838666** · PHASE1,PHASE2 · TERMINATED · sponsor: **Bioinova, s.r.o.** · enrollment: 9 (actual)

## Conditions studied

- Rotator Cuff Tear

## Interventions

- **DRUG:** Suspension of human autologous MSC 3P

## Key facts

- **NCT ID:** NCT03838666
- **Lead sponsor:** Bioinova, s.r.o.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-12-12
- **Primary completion:** 2015-11-18
- **Final completion:** 2015-11-18
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** Primary endpoint (safety) has been achieved
- **Last updated:** 2019-02-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03838666

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03838666, "Utilization of AMSC to Enhance Rotator Cuff Repair - Safety and Efficacy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03838666. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*